bibliographic resource 349810 [br/349810]
https://w3id.org/oc/corpus/br/349810
- is a
-
- title
-
- Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial
- publication date
-
- contributor
-
- format
-
- identifier
-
- part of
-